nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—SSTR5—epilepsy syndrome	0.199	0.282	CbGaD
Pasireotide—SSTR1—epilepsy syndrome	0.178	0.252	CbGaD
Pasireotide—SSTR3—epilepsy syndrome	0.178	0.252	CbGaD
Pasireotide—SSTR2—epilepsy syndrome	0.151	0.214	CbGaD
Pasireotide—SSTR5—hindbrain—epilepsy syndrome	0.00542	0.0936	CbGeAlD
Pasireotide—SSTR3—hindbrain—epilepsy syndrome	0.00519	0.0898	CbGeAlD
Pasireotide—SSTR1—hindbrain—epilepsy syndrome	0.0041	0.071	CbGeAlD
Pasireotide—SSTR2—hindbrain—epilepsy syndrome	0.00349	0.0603	CbGeAlD
Pasireotide—SSTR5—brainstem—epilepsy syndrome	0.0031	0.0537	CbGeAlD
Pasireotide—SSTR3—brainstem—epilepsy syndrome	0.00298	0.0515	CbGeAlD
Pasireotide—SSTR1—brainstem—epilepsy syndrome	0.00235	0.0407	CbGeAlD
Pasireotide—SSTR1—forebrain—epilepsy syndrome	0.00227	0.0393	CbGeAlD
Pasireotide—SSTR1—telencephalon—epilepsy syndrome	0.00209	0.0361	CbGeAlD
Pasireotide—SSTR2—brainstem—epilepsy syndrome	0.002	0.0346	CbGeAlD
Pasireotide—SSTR2—forebrain—epilepsy syndrome	0.00193	0.0334	CbGeAlD
Pasireotide—SSTR2—telencephalon—epilepsy syndrome	0.00178	0.0307	CbGeAlD
Pasireotide—SSTR3—head—epilepsy syndrome	0.00164	0.0284	CbGeAlD
Pasireotide—SSTR3—nervous system—epilepsy syndrome	0.00156	0.027	CbGeAlD
Pasireotide—SSTR5—cerebellum—epilepsy syndrome	0.00153	0.0265	CbGeAlD
Pasireotide—SSTR3—central nervous system—epilepsy syndrome	0.0015	0.026	CbGeAlD
Pasireotide—SSTR1—midbrain—epilepsy syndrome	0.0015	0.0259	CbGeAlD
Pasireotide—SSTR3—cerebellum—epilepsy syndrome	0.00147	0.0254	CbGeAlD
Pasireotide—SSTR1—head—epilepsy syndrome	0.0013	0.0225	CbGeAlD
Pasireotide—SSTR1—nervous system—epilepsy syndrome	0.00123	0.0213	CbGeAlD
Pasireotide—SSTR3—brain—epilepsy syndrome	0.00119	0.0206	CbGeAlD
Pasireotide—SSTR1—central nervous system—epilepsy syndrome	0.00119	0.0205	CbGeAlD
Pasireotide—Octreotide—SSTR4—epilepsy syndrome	0.00118	0.217	CrCbGaD
Pasireotide—SSTR1—cerebellum—epilepsy syndrome	0.00116	0.0201	CbGeAlD
Pasireotide—SSTR2—head—epilepsy syndrome	0.00111	0.0191	CbGeAlD
Pasireotide—SSTR2—nervous system—epilepsy syndrome	0.00105	0.0181	CbGeAlD
Pasireotide—SSTR2—central nervous system—epilepsy syndrome	0.00101	0.0174	CbGeAlD
Pasireotide—SSTR2—cerebellum—epilepsy syndrome	0.000986	0.0171	CbGeAlD
Pasireotide—SSTR1—brain—epilepsy syndrome	0.000942	0.0163	CbGeAlD
Pasireotide—Vapreotide—SSTR5—epilepsy syndrome	0.000869	0.16	CrCbGaD
Pasireotide—SSTR2—brain—epilepsy syndrome	0.000801	0.0138	CbGeAlD
Pasireotide—Octreotide—SSTR5—epilepsy syndrome	0.000759	0.14	CrCbGaD
Pasireotide—Octreotide—SSTR1—epilepsy syndrome	0.000677	0.124	CrCbGaD
Pasireotide—Octreotide—SSTR3—epilepsy syndrome	0.000677	0.124	CrCbGaD
Pasireotide—Vapreotide—SSTR2—epilepsy syndrome	0.000658	0.121	CrCbGaD
Pasireotide—Octreotide—SSTR2—epilepsy syndrome	0.000575	0.106	CrCbGaD
Pasireotide—Abdominal pain—Levetiracetam—epilepsy syndrome	0.000143	0.00138	CcSEcCtD
Pasireotide—Hypotension—Clonazepam—epilepsy syndrome	0.000143	0.00138	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Topiramate—epilepsy syndrome	0.000142	0.00137	CcSEcCtD
Pasireotide—Hypotension—Phenytoin—epilepsy syndrome	0.000142	0.00137	CcSEcCtD
Pasireotide—Headache—Clobazam—epilepsy syndrome	0.000142	0.00137	CcSEcCtD
Pasireotide—Nasopharyngitis—Topiramate—epilepsy syndrome	0.000141	0.00136	CcSEcCtD
Pasireotide—Hypotension—Oxcarbazepine—epilepsy syndrome	0.000141	0.00136	CcSEcCtD
Pasireotide—Decreased appetite—Felbamate—epilepsy syndrome	0.000141	0.00136	CcSEcCtD
Pasireotide—Fatigue—Felbamate—epilepsy syndrome	0.00014	0.00135	CcSEcCtD
Pasireotide—Oedema peripheral—Pregabalin—epilepsy syndrome	0.00014	0.00135	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Topiramate—epilepsy syndrome	0.00014	0.00135	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Clonazepam—epilepsy syndrome	0.000139	0.00135	CcSEcCtD
Pasireotide—Gastrointestinal pain—Vigabatrin—epilepsy syndrome	0.000139	0.00134	CcSEcCtD
Pasireotide—Constipation—Felbamate—epilepsy syndrome	0.000139	0.00134	CcSEcCtD
Pasireotide—Alopecia—Valproic Acid—epilepsy syndrome	0.000139	0.00134	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Phenytoin—epilepsy syndrome	0.000139	0.00134	CcSEcCtD
Pasireotide—Nausea—Lacosamide—epilepsy syndrome	0.000139	0.00134	CcSEcCtD
Pasireotide—Insomnia—Clonazepam—epilepsy syndrome	0.000138	0.00134	CcSEcCtD
Pasireotide—Decreased appetite—Zonisamide—epilepsy syndrome	0.000138	0.00133	CcSEcCtD
Pasireotide—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000138	0.00133	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Oxcarbazepine—epilepsy syndrome	0.000138	0.00133	CcSEcCtD
Pasireotide—Abdominal distension—Topiramate—epilepsy syndrome	0.000138	0.00133	CcSEcCtD
Pasireotide—Insomnia—Phenytoin—epilepsy syndrome	0.000138	0.00133	CcSEcCtD
Pasireotide—Gastrointestinal pain—Diazepam—epilepsy syndrome	0.000137	0.00132	CcSEcCtD
Pasireotide—Fatigue—Zonisamide—epilepsy syndrome	0.000137	0.00132	CcSEcCtD
Pasireotide—Insomnia—Oxcarbazepine—epilepsy syndrome	0.000137	0.00132	CcSEcCtD
Pasireotide—Constipation—Zonisamide—epilepsy syndrome	0.000136	0.00131	CcSEcCtD
Pasireotide—Hypotension—Carbamazepine—epilepsy syndrome	0.000136	0.00131	CcSEcCtD
Pasireotide—Abdominal pain—Vigabatrin—epilepsy syndrome	0.000135	0.0013	CcSEcCtD
Pasireotide—Nausea—Clobazam—epilepsy syndrome	0.000134	0.0013	CcSEcCtD
Pasireotide—Asthenia—Propofol—epilepsy syndrome	0.000134	0.0013	CcSEcCtD
Pasireotide—Dizziness—Acetazolamide—epilepsy syndrome	0.000133	0.00129	CcSEcCtD
Pasireotide—Decreased appetite—Clonazepam—epilepsy syndrome	0.000133	0.00128	CcSEcCtD
Pasireotide—Gastrointestinal pain—Felbamate—epilepsy syndrome	0.000133	0.00128	CcSEcCtD
Pasireotide—Pruritus—Propofol—epilepsy syndrome	0.000133	0.00128	CcSEcCtD
Pasireotide—Abdominal pain—Diazepam—epilepsy syndrome	0.000133	0.00128	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	0.000132	0.00128	CcSEcCtD
Pasireotide—Decreased appetite—Phenytoin—epilepsy syndrome	0.000132	0.00128	CcSEcCtD
Pasireotide—Back pain—Valproic Acid—epilepsy syndrome	0.000132	0.00127	CcSEcCtD
Pasireotide—Fatigue—Clonazepam—epilepsy syndrome	0.000132	0.00127	CcSEcCtD
Pasireotide—Asthenia—Midazolam—epilepsy syndrome	0.000132	0.00127	CcSEcCtD
Pasireotide—Decreased appetite—Oxcarbazepine—epilepsy syndrome	0.000131	0.00127	CcSEcCtD
Pasireotide—Insomnia—Carbamazepine—epilepsy syndrome	0.000131	0.00127	CcSEcCtD
Pasireotide—Fatigue—Phenytoin—epilepsy syndrome	0.000131	0.00126	CcSEcCtD
Pasireotide—Constipation—Clonazepam—epilepsy syndrome	0.000131	0.00126	CcSEcCtD
Pasireotide—Fatigue—Oxcarbazepine—epilepsy syndrome	0.00013	0.00126	CcSEcCtD
Pasireotide—Constipation—Phenytoin—epilepsy syndrome	0.00013	0.00125	CcSEcCtD
Pasireotide—Gastrointestinal pain—Zonisamide—epilepsy syndrome	0.00013	0.00125	CcSEcCtD
Pasireotide—Asthenia—Levetiracetam—epilepsy syndrome	0.00013	0.00125	CcSEcCtD
Pasireotide—Pruritus—Midazolam—epilepsy syndrome	0.00013	0.00125	CcSEcCtD
Pasireotide—Constipation—Oxcarbazepine—epilepsy syndrome	0.000129	0.00125	CcSEcCtD
Pasireotide—Abdominal pain—Felbamate—epilepsy syndrome	0.000128	0.00124	CcSEcCtD
Pasireotide—Vomiting—Acetazolamide—epilepsy syndrome	0.000128	0.00124	CcSEcCtD
Pasireotide—Diarrhoea—Propofol—epilepsy syndrome	0.000128	0.00124	CcSEcCtD
Pasireotide—Oedema peripheral—Gabapentin—epilepsy syndrome	0.000128	0.00124	CcSEcCtD
Pasireotide—Pruritus—Levetiracetam—epilepsy syndrome	0.000128	0.00124	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	0.000128	0.00123	CcSEcCtD
Pasireotide—Insomnia—Lamotrigine—epilepsy syndrome	0.000127	0.00122	CcSEcCtD
Pasireotide—Headache—Acetazolamide—epilepsy syndrome	0.000126	0.00122	CcSEcCtD
Pasireotide—Anaemia—Valproic Acid—epilepsy syndrome	0.000126	0.00122	CcSEcCtD
Pasireotide—Decreased appetite—Carbamazepine—epilepsy syndrome	0.000126	0.00122	CcSEcCtD
Pasireotide—Abdominal pain—Zonisamide—epilepsy syndrome	0.000126	0.00121	CcSEcCtD
Pasireotide—Asthenia—Fosphenytoin—epilepsy syndrome	0.000125	0.00121	CcSEcCtD
Pasireotide—Alopecia—Pregabalin—epilepsy syndrome	0.000125	0.00121	CcSEcCtD
Pasireotide—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.000125	0.00121	CcSEcCtD
Pasireotide—Fatigue—Carbamazepine—epilepsy syndrome	0.000125	0.00121	CcSEcCtD
Pasireotide—Constipation—Carbamazepine—epilepsy syndrome	0.000124	0.0012	CcSEcCtD
Pasireotide—Dizziness—Propofol—epilepsy syndrome	0.000124	0.0012	CcSEcCtD
Pasireotide—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000124	0.0012	CcSEcCtD
Pasireotide—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000124	0.00119	CcSEcCtD
Pasireotide—Pruritus—Fosphenytoin—epilepsy syndrome	0.000124	0.00119	CcSEcCtD
Pasireotide—Hyperglycaemia—Topiramate—epilepsy syndrome	0.000123	0.00119	CcSEcCtD
Pasireotide—Vertigo—Valproic Acid—epilepsy syndrome	0.000123	0.00118	CcSEcCtD
Pasireotide—Asthenia—Vigabatrin—epilepsy syndrome	0.000122	0.00118	CcSEcCtD
Pasireotide—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000122	0.00118	CcSEcCtD
Pasireotide—Dizziness—Midazolam—epilepsy syndrome	0.000121	0.00117	CcSEcCtD
Pasireotide—Abdominal pain—Clonazepam—epilepsy syndrome	0.000121	0.00117	CcSEcCtD
Pasireotide—Fatigue—Lamotrigine—epilepsy syndrome	0.000121	0.00117	CcSEcCtD
Pasireotide—Pruritus—Vigabatrin—epilepsy syndrome	0.00012	0.00116	CcSEcCtD
Pasireotide—Asthenia—Diazepam—epilepsy syndrome	0.00012	0.00116	CcSEcCtD
Pasireotide—Constipation—Lamotrigine—epilepsy syndrome	0.00012	0.00116	CcSEcCtD
Pasireotide—Nausea—Acetazolamide—epilepsy syndrome	0.00012	0.00116	CcSEcCtD
Pasireotide—Dizziness—Levetiracetam—epilepsy syndrome	0.00012	0.00116	CcSEcCtD
Pasireotide—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.00012	0.00115	CcSEcCtD
Pasireotide—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.00012	0.00115	CcSEcCtD
Pasireotide—Back pain—Pregabalin—epilepsy syndrome	0.000119	0.00115	CcSEcCtD
Pasireotide—Vomiting—Propofol—epilepsy syndrome	0.000119	0.00115	CcSEcCtD
Pasireotide—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000119	0.00115	CcSEcCtD
Pasireotide—Pruritus—Diazepam—epilepsy syndrome	0.000119	0.00114	CcSEcCtD
Pasireotide—Hypertension—Valproic Acid—epilepsy syndrome	0.000118	0.00114	CcSEcCtD
Pasireotide—Headache—Propofol—epilepsy syndrome	0.000117	0.00113	CcSEcCtD
Pasireotide—Vomiting—Midazolam—epilepsy syndrome	0.000117	0.00112	CcSEcCtD
Pasireotide—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000117	0.00112	CcSEcCtD
Pasireotide—Asthenia—Felbamate—epilepsy syndrome	0.000116	0.00112	CcSEcCtD
Pasireotide—Myalgia—Valproic Acid—epilepsy syndrome	0.000116	0.00112	CcSEcCtD
Pasireotide—Arthralgia—Valproic Acid—epilepsy syndrome	0.000116	0.00112	CcSEcCtD
Pasireotide—Anxiety—Valproic Acid—epilepsy syndrome	0.000116	0.00112	CcSEcCtD
Pasireotide—Dizziness—Fosphenytoin—epilepsy syndrome	0.000116	0.00111	CcSEcCtD
Pasireotide—Vomiting—Levetiracetam—epilepsy syndrome	0.000115	0.00111	CcSEcCtD
Pasireotide—Alopecia—Gabapentin—epilepsy syndrome	0.000115	0.00111	CcSEcCtD
Pasireotide—Headache—Midazolam—epilepsy syndrome	0.000115	0.00111	CcSEcCtD
Pasireotide—Pruritus—Felbamate—epilepsy syndrome	0.000115	0.00111	CcSEcCtD
Pasireotide—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000115	0.00111	CcSEcCtD
Pasireotide—Diarrhoea—Diazepam—epilepsy syndrome	0.000115	0.00111	CcSEcCtD
Pasireotide—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000115	0.00111	CcSEcCtD
Pasireotide—Anaemia—Pregabalin—epilepsy syndrome	0.000114	0.0011	CcSEcCtD
Pasireotide—Asthenia—Zonisamide—epilepsy syndrome	0.000114	0.0011	CcSEcCtD
Pasireotide—Headache—Levetiracetam—epilepsy syndrome	0.000113	0.00109	CcSEcCtD
Pasireotide—Dizziness—Vigabatrin—epilepsy syndrome	0.000113	0.00109	CcSEcCtD
Pasireotide—Pruritus—Zonisamide—epilepsy syndrome	0.000112	0.00108	CcSEcCtD
Pasireotide—Nausea—Propofol—epilepsy syndrome	0.000111	0.00107	CcSEcCtD
Pasireotide—Vomiting—Fosphenytoin—epilepsy syndrome	0.000111	0.00107	CcSEcCtD
Pasireotide—Diarrhoea—Felbamate—epilepsy syndrome	0.000111	0.00107	CcSEcCtD
Pasireotide—Vertigo—Pregabalin—epilepsy syndrome	0.000111	0.00107	CcSEcCtD
Pasireotide—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000111	0.00107	CcSEcCtD
Pasireotide—Dizziness—Diazepam—epilepsy syndrome	0.000111	0.00107	CcSEcCtD
Pasireotide—Asthenia—Clonazepam—epilepsy syndrome	0.00011	0.00106	CcSEcCtD
Pasireotide—Back pain—Gabapentin—epilepsy syndrome	0.00011	0.00106	CcSEcCtD
Pasireotide—Headache—Fosphenytoin—epilepsy syndrome	0.000109	0.00106	CcSEcCtD
Pasireotide—Asthenia—Phenytoin—epilepsy syndrome	0.000109	0.00105	CcSEcCtD
Pasireotide—Nausea—Midazolam—epilepsy syndrome	0.000109	0.00105	CcSEcCtD
Pasireotide—Diarrhoea—Zonisamide—epilepsy syndrome	0.000109	0.00105	CcSEcCtD
Pasireotide—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000109	0.00105	CcSEcCtD
Pasireotide—Pruritus—Clonazepam—epilepsy syndrome	0.000108	0.00105	CcSEcCtD
Pasireotide—Vomiting—Vigabatrin—epilepsy syndrome	0.000108	0.00104	CcSEcCtD
Pasireotide—Oedema peripheral—Topiramate—epilepsy syndrome	0.000108	0.00104	CcSEcCtD
Pasireotide—Pruritus—Phenytoin—epilepsy syndrome	0.000108	0.00104	CcSEcCtD
Pasireotide—Nausea—Levetiracetam—epilepsy syndrome	0.000108	0.00104	CcSEcCtD
Pasireotide—Dizziness—Felbamate—epilepsy syndrome	0.000107	0.00104	CcSEcCtD
Pasireotide—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000107	0.00103	CcSEcCtD
Pasireotide—Headache—Vigabatrin—epilepsy syndrome	0.000107	0.00103	CcSEcCtD
Pasireotide—Hypertension—Pregabalin—epilepsy syndrome	0.000107	0.00103	CcSEcCtD
Pasireotide—Vomiting—Diazepam—epilepsy syndrome	0.000107	0.00103	CcSEcCtD
Pasireotide—Myalgia—Pregabalin—epilepsy syndrome	0.000105	0.00101	CcSEcCtD
Pasireotide—Arthralgia—Pregabalin—epilepsy syndrome	0.000105	0.00101	CcSEcCtD
Pasireotide—Dizziness—Zonisamide—epilepsy syndrome	0.000105	0.00101	CcSEcCtD
Pasireotide—Headache—Diazepam—epilepsy syndrome	0.000105	0.00101	CcSEcCtD
Pasireotide—Anxiety—Pregabalin—epilepsy syndrome	0.000105	0.00101	CcSEcCtD
Pasireotide—Diarrhoea—Clonazepam—epilepsy syndrome	0.000105	0.00101	CcSEcCtD
Pasireotide—Anaemia—Gabapentin—epilepsy syndrome	0.000105	0.00101	CcSEcCtD
Pasireotide—Hypotension—Valproic Acid—epilepsy syndrome	0.000104	0.00101	CcSEcCtD
Pasireotide—Asthenia—Carbamazepine—epilepsy syndrome	0.000104	0.001	CcSEcCtD
Pasireotide—Diarrhoea—Phenytoin—epilepsy syndrome	0.000104	0.001	CcSEcCtD
Pasireotide—Nausea—Fosphenytoin—epilepsy syndrome	0.000104	0.001	CcSEcCtD
Pasireotide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000103	0.000999	CcSEcCtD
Pasireotide—Vomiting—Felbamate—epilepsy syndrome	0.000103	0.000996	CcSEcCtD
Pasireotide—Pruritus—Carbamazepine—epilepsy syndrome	0.000103	0.000991	CcSEcCtD
Pasireotide—Vertigo—Gabapentin—epilepsy syndrome	0.000102	0.000982	CcSEcCtD
Pasireotide—Headache—Felbamate—epilepsy syndrome	0.000102	0.000981	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000102	0.00098	CcSEcCtD
Pasireotide—Dizziness—Clonazepam—epilepsy syndrome	0.000101	0.000977	CcSEcCtD
Pasireotide—Nausea—Vigabatrin—epilepsy syndrome	0.000101	0.000976	CcSEcCtD
Pasireotide—Vomiting—Zonisamide—epilepsy syndrome	0.000101	0.000974	CcSEcCtD
Pasireotide—Insomnia—Valproic Acid—epilepsy syndrome	0.000101	0.000973	CcSEcCtD
Pasireotide—Asthenia—Lamotrigine—epilepsy syndrome	0.000101	0.000971	CcSEcCtD
Pasireotide—Dizziness—Phenytoin—epilepsy syndrome	0.000101	0.00097	CcSEcCtD
Pasireotide—Dizziness—Oxcarbazepine—epilepsy syndrome	0.0001	0.000965	CcSEcCtD
Pasireotide—Nausea—Diazepam—epilepsy syndrome	9.96e-05	0.000961	CcSEcCtD
Pasireotide—Headache—Zonisamide—epilepsy syndrome	9.95e-05	0.00096	CcSEcCtD
Pasireotide—Diarrhoea—Carbamazepine—epilepsy syndrome	9.93e-05	0.000958	CcSEcCtD
Pasireotide—Pruritus—Lamotrigine—epilepsy syndrome	9.93e-05	0.000958	CcSEcCtD
Pasireotide—Hypertension—Gabapentin—epilepsy syndrome	9.78e-05	0.000943	CcSEcCtD
Pasireotide—Vomiting—Clonazepam—epilepsy syndrome	9.73e-05	0.000939	CcSEcCtD
Pasireotide—Decreased appetite—Valproic Acid—epilepsy syndrome	9.69e-05	0.000935	CcSEcCtD
Pasireotide—Alopecia—Topiramate—epilepsy syndrome	9.67e-05	0.000933	CcSEcCtD
Pasireotide—Vomiting—Phenytoin—epilepsy syndrome	9.67e-05	0.000933	CcSEcCtD
Pasireotide—Arthralgia—Gabapentin—epilepsy syndrome	9.64e-05	0.00093	CcSEcCtD
Pasireotide—Myalgia—Gabapentin—epilepsy syndrome	9.64e-05	0.00093	CcSEcCtD
Pasireotide—Nausea—Felbamate—epilepsy syndrome	9.64e-05	0.00093	CcSEcCtD
Pasireotide—Vomiting—Oxcarbazepine—epilepsy syndrome	9.62e-05	0.000928	CcSEcCtD
Pasireotide—Fatigue—Valproic Acid—epilepsy syndrome	9.61e-05	0.000927	CcSEcCtD
Pasireotide—Anxiety—Gabapentin—epilepsy syndrome	9.61e-05	0.000927	CcSEcCtD
Pasireotide—Dizziness—Carbamazepine—epilepsy syndrome	9.6e-05	0.000926	CcSEcCtD
Pasireotide—Diarrhoea—Lamotrigine—epilepsy syndrome	9.6e-05	0.000926	CcSEcCtD
Pasireotide—Headache—Clonazepam—epilepsy syndrome	9.59e-05	0.000925	CcSEcCtD
Pasireotide—Constipation—Valproic Acid—epilepsy syndrome	9.53e-05	0.00092	CcSEcCtD
Pasireotide—Headache—Phenytoin—epilepsy syndrome	9.53e-05	0.000919	CcSEcCtD
Pasireotide—Headache—Oxcarbazepine—epilepsy syndrome	9.48e-05	0.000914	CcSEcCtD
Pasireotide—Nausea—Zonisamide—epilepsy syndrome	9.44e-05	0.00091	CcSEcCtD
Pasireotide—Hypotension—Pregabalin—epilepsy syndrome	9.42e-05	0.000909	CcSEcCtD
Pasireotide—Dizziness—Lamotrigine—epilepsy syndrome	9.28e-05	0.000895	CcSEcCtD
Pasireotide—Vomiting—Carbamazepine—epilepsy syndrome	9.23e-05	0.00089	CcSEcCtD
Pasireotide—Back pain—Topiramate—epilepsy syndrome	9.21e-05	0.000889	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	9.18e-05	0.000886	CcSEcCtD
Pasireotide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	9.12e-05	0.00088	CcSEcCtD
Pasireotide—Insomnia—Pregabalin—epilepsy syndrome	9.12e-05	0.000879	CcSEcCtD
Pasireotide—Nausea—Clonazepam—epilepsy syndrome	9.09e-05	0.000877	CcSEcCtD
Pasireotide—Headache—Carbamazepine—epilepsy syndrome	9.09e-05	0.000877	CcSEcCtD
Pasireotide—Nausea—Phenytoin—epilepsy syndrome	9.03e-05	0.000871	CcSEcCtD
Pasireotide—Nausea—Oxcarbazepine—epilepsy syndrome	8.98e-05	0.000867	CcSEcCtD
Pasireotide—Vomiting—Lamotrigine—epilepsy syndrome	8.92e-05	0.000861	CcSEcCtD
Pasireotide—Abdominal pain—Valproic Acid—epilepsy syndrome	8.81e-05	0.00085	CcSEcCtD
Pasireotide—Anaemia—Topiramate—epilepsy syndrome	8.8e-05	0.00085	CcSEcCtD
Pasireotide—Headache—Lamotrigine—epilepsy syndrome	8.79e-05	0.000848	CcSEcCtD
Pasireotide—Decreased appetite—Pregabalin—epilepsy syndrome	8.76e-05	0.000845	CcSEcCtD
Pasireotide—Fatigue—Pregabalin—epilepsy syndrome	8.69e-05	0.000838	CcSEcCtD
Pasireotide—Hypotension—Gabapentin—epilepsy syndrome	8.64e-05	0.000833	CcSEcCtD
Pasireotide—Nausea—Carbamazepine—epilepsy syndrome	8.62e-05	0.000832	CcSEcCtD
Pasireotide—Constipation—Pregabalin—epilepsy syndrome	8.62e-05	0.000832	CcSEcCtD
Pasireotide—Vertigo—Topiramate—epilepsy syndrome	8.56e-05	0.000826	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	8.42e-05	0.000812	CcSEcCtD
Pasireotide—Insomnia—Gabapentin—epilepsy syndrome	8.36e-05	0.000806	CcSEcCtD
Pasireotide—Nausea—Lamotrigine—epilepsy syndrome	8.33e-05	0.000804	CcSEcCtD
Pasireotide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	8.24e-05	0.000795	CcSEcCtD
Pasireotide—Hypertension—Topiramate—epilepsy syndrome	8.22e-05	0.000794	CcSEcCtD
Pasireotide—Myalgia—Topiramate—epilepsy syndrome	8.11e-05	0.000783	CcSEcCtD
Pasireotide—Arthralgia—Topiramate—epilepsy syndrome	8.11e-05	0.000783	CcSEcCtD
Pasireotide—Anxiety—Topiramate—epilepsy syndrome	8.08e-05	0.00078	CcSEcCtD
Pasireotide—Decreased appetite—Gabapentin—epilepsy syndrome	8.03e-05	0.000775	CcSEcCtD
Pasireotide—Asthenia—Valproic Acid—epilepsy syndrome	8e-05	0.000772	CcSEcCtD
Pasireotide—Fatigue—Gabapentin—epilepsy syndrome	7.97e-05	0.000769	CcSEcCtD
Pasireotide—Abdominal pain—Pregabalin—epilepsy syndrome	7.97e-05	0.000769	CcSEcCtD
Pasireotide—Constipation—Gabapentin—epilepsy syndrome	7.9e-05	0.000762	CcSEcCtD
Pasireotide—Pruritus—Valproic Acid—epilepsy syndrome	7.89e-05	0.000761	CcSEcCtD
Pasireotide—Diarrhoea—Valproic Acid—epilepsy syndrome	7.63e-05	0.000736	CcSEcCtD
Pasireotide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	7.56e-05	0.000729	CcSEcCtD
Pasireotide—Dizziness—Valproic Acid—epilepsy syndrome	7.37e-05	0.000711	CcSEcCtD
Pasireotide—Abdominal pain—Gabapentin—epilepsy syndrome	7.31e-05	0.000705	CcSEcCtD
Pasireotide—Hypotension—Topiramate—epilepsy syndrome	7.26e-05	0.000701	CcSEcCtD
Pasireotide—Asthenia—Pregabalin—epilepsy syndrome	7.23e-05	0.000698	CcSEcCtD
Pasireotide—Pruritus—Pregabalin—epilepsy syndrome	7.13e-05	0.000688	CcSEcCtD
Pasireotide—Vomiting—Valproic Acid—epilepsy syndrome	7.09e-05	0.000684	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	7.08e-05	0.000683	CcSEcCtD
Pasireotide—Insomnia—Topiramate—epilepsy syndrome	7.03e-05	0.000678	CcSEcCtD
Pasireotide—Headache—Valproic Acid—epilepsy syndrome	6.98e-05	0.000674	CcSEcCtD
Pasireotide—Diarrhoea—Pregabalin—epilepsy syndrome	6.9e-05	0.000665	CcSEcCtD
Pasireotide—Decreased appetite—Topiramate—epilepsy syndrome	6.76e-05	0.000652	CcSEcCtD
Pasireotide—Fatigue—Topiramate—epilepsy syndrome	6.7e-05	0.000647	CcSEcCtD
Pasireotide—Dizziness—Pregabalin—epilepsy syndrome	6.66e-05	0.000643	CcSEcCtD
Pasireotide—Constipation—Topiramate—epilepsy syndrome	6.65e-05	0.000641	CcSEcCtD
Pasireotide—Asthenia—Gabapentin—epilepsy syndrome	6.63e-05	0.00064	CcSEcCtD
Pasireotide—Nausea—Valproic Acid—epilepsy syndrome	6.62e-05	0.000639	CcSEcCtD
Pasireotide—Pruritus—Gabapentin—epilepsy syndrome	6.54e-05	0.000631	CcSEcCtD
Pasireotide—Vomiting—Pregabalin—epilepsy syndrome	6.41e-05	0.000618	CcSEcCtD
Pasireotide—Gastrointestinal pain—Topiramate—epilepsy syndrome	6.36e-05	0.000613	CcSEcCtD
Pasireotide—Diarrhoea—Gabapentin—epilepsy syndrome	6.32e-05	0.00061	CcSEcCtD
Pasireotide—Headache—Pregabalin—epilepsy syndrome	6.31e-05	0.000609	CcSEcCtD
Pasireotide—Abdominal pain—Topiramate—epilepsy syndrome	6.15e-05	0.000593	CcSEcCtD
Pasireotide—Dizziness—Gabapentin—epilepsy syndrome	6.11e-05	0.00059	CcSEcCtD
Pasireotide—Nausea—Pregabalin—epilepsy syndrome	5.99e-05	0.000578	CcSEcCtD
Pasireotide—Vomiting—Gabapentin—epilepsy syndrome	5.88e-05	0.000567	CcSEcCtD
Pasireotide—Headache—Gabapentin—epilepsy syndrome	5.79e-05	0.000559	CcSEcCtD
Pasireotide—Asthenia—Topiramate—epilepsy syndrome	5.58e-05	0.000538	CcSEcCtD
Pasireotide—Pruritus—Topiramate—epilepsy syndrome	5.5e-05	0.000531	CcSEcCtD
Pasireotide—Nausea—Gabapentin—epilepsy syndrome	5.49e-05	0.00053	CcSEcCtD
Pasireotide—Diarrhoea—Topiramate—epilepsy syndrome	5.32e-05	0.000513	CcSEcCtD
Pasireotide—Dizziness—Topiramate—epilepsy syndrome	5.14e-05	0.000496	CcSEcCtD
Pasireotide—Vomiting—Topiramate—epilepsy syndrome	4.94e-05	0.000477	CcSEcCtD
Pasireotide—Headache—Topiramate—epilepsy syndrome	4.87e-05	0.00047	CcSEcCtD
Pasireotide—Nausea—Topiramate—epilepsy syndrome	4.62e-05	0.000446	CcSEcCtD
Pasireotide—Desmopressin—PTGS2—epilepsy syndrome	4.47e-05	0.00822	CrCbGaD
Pasireotide—SSTR3—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.77e-05	0.000139	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PTK2B—epilepsy syndrome	1.76e-05	0.000139	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TSC1—epilepsy syndrome	1.76e-05	0.000139	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.76e-05	0.000138	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—CCR5—epilepsy syndrome	1.75e-05	0.000138	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—AGT—epilepsy syndrome	1.74e-05	0.000137	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—AVP—epilepsy syndrome	1.73e-05	0.000136	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SST—epilepsy syndrome	1.72e-05	0.000135	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NTRK2—epilepsy syndrome	1.72e-05	0.000135	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCR3—epilepsy syndrome	1.72e-05	0.000135	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCR2—epilepsy syndrome	1.72e-05	0.000135	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.72e-05	0.000135	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HRH3—epilepsy syndrome	1.7e-05	0.000134	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—DUSP6—epilepsy syndrome	1.7e-05	0.000134	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.7e-05	0.000133	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PTK2B—epilepsy syndrome	1.69e-05	0.000133	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TSC1—epilepsy syndrome	1.69e-05	0.000133	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—ADRA2A—epilepsy syndrome	1.68e-05	0.000132	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—OPRM1—epilepsy syndrome	1.68e-05	0.000132	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NPY—epilepsy syndrome	1.67e-05	0.000131	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PLAT—epilepsy syndrome	1.67e-05	0.000131	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ATP2A2—epilepsy syndrome	1.67e-05	0.000131	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—AGT—epilepsy syndrome	1.67e-05	0.000131	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCR2—epilepsy syndrome	1.65e-05	0.000129	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SST—epilepsy syndrome	1.65e-05	0.000129	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NTRK2—epilepsy syndrome	1.65e-05	0.000129	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—DUSP6—epilepsy syndrome	1.63e-05	0.000128	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—AGT—epilepsy syndrome	1.63e-05	0.000128	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—CCR5—epilepsy syndrome	1.62e-05	0.000127	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CXCL12—epilepsy syndrome	1.61e-05	0.000127	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—BDKRB2—epilepsy syndrome	1.61e-05	0.000127	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HSPB1—epilepsy syndrome	1.61e-05	0.000127	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCL3—epilepsy syndrome	1.61e-05	0.000127	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—OXT—epilepsy syndrome	1.61e-05	0.000127	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CXCL2—epilepsy syndrome	1.61e-05	0.000127	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CRH—epilepsy syndrome	1.61e-05	0.000127	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—POMC—epilepsy syndrome	1.61e-05	0.000127	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.61e-05	0.000127	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PRKCB—epilepsy syndrome	1.61e-05	0.000126	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PLAT—epilepsy syndrome	1.6e-05	0.000126	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—IL6ST—epilepsy syndrome	1.6e-05	0.000126	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CCR5—epilepsy syndrome	1.59e-05	0.000125	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—JUNB—epilepsy syndrome	1.58e-05	0.000124	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CNR1—epilepsy syndrome	1.58e-05	0.000124	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCR3—epilepsy syndrome	1.58e-05	0.000124	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.58e-05	0.000124	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PLCB1—epilepsy syndrome	1.58e-05	0.000124	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—HTR2A—epilepsy syndrome	1.56e-05	0.000122	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CXCL12—epilepsy syndrome	1.55e-05	0.000122	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.55e-05	0.000122	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—HTR7—epilepsy syndrome	1.55e-05	0.000121	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—POMC—epilepsy syndrome	1.54e-05	0.000121	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NPY—epilepsy syndrome	1.54e-05	0.000121	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ATP2A2—epilepsy syndrome	1.54e-05	0.000121	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.54e-05	0.000121	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.53e-05	0.000121	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—JUNB—epilepsy syndrome	1.52e-05	0.000119	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CNR1—epilepsy syndrome	1.52e-05	0.000119	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PLCB1—epilepsy syndrome	1.51e-05	0.000119	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.5e-05	0.000118	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—AGT—epilepsy syndrome	1.5e-05	0.000118	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—HBEGF—epilepsy syndrome	1.5e-05	0.000118	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TSC1—epilepsy syndrome	1.5e-05	0.000118	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PTK2B—epilepsy syndrome	1.5e-05	0.000118	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HSPB1—epilepsy syndrome	1.49e-05	0.000117	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CRH—epilepsy syndrome	1.49e-05	0.000117	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCL3—epilepsy syndrome	1.49e-05	0.000117	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—OXT—epilepsy syndrome	1.49e-05	0.000117	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CXCL2—epilepsy syndrome	1.49e-05	0.000117	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—HTR7—epilepsy syndrome	1.48e-05	0.000116	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—AGT—epilepsy syndrome	1.48e-05	0.000116	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—AKT3—epilepsy syndrome	1.47e-05	0.000116	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CCR5—epilepsy syndrome	1.47e-05	0.000115	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—POMC—epilepsy syndrome	1.46e-05	0.000115	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCR2—epilepsy syndrome	1.46e-05	0.000115	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NTRK2—epilepsy syndrome	1.46e-05	0.000115	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SST—epilepsy syndrome	1.46e-05	0.000115	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—DUSP6—epilepsy syndrome	1.45e-05	0.000114	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—HBEGF—epilepsy syndrome	1.44e-05	0.000113	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—ADAM10—epilepsy syndrome	1.44e-05	0.000113	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—HTR2A—epilepsy syndrome	1.44e-05	0.000113	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—CCL2—epilepsy syndrome	1.43e-05	0.000113	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ADRA2A—epilepsy syndrome	1.43e-05	0.000112	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PLAT—epilepsy syndrome	1.42e-05	0.000112	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—AKT3—epilepsy syndrome	1.41e-05	0.000111	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—POMC—epilepsy syndrome	1.4e-05	0.00011	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.39e-05	0.000109	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TSC1—epilepsy syndrome	1.38e-05	0.000109	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PTK2B—epilepsy syndrome	1.38e-05	0.000109	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—ADAM10—epilepsy syndrome	1.38e-05	0.000108	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CCL2—epilepsy syndrome	1.37e-05	0.000108	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—BDKRB2—epilepsy syndrome	1.37e-05	0.000108	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CXCL12—epilepsy syndrome	1.37e-05	0.000108	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—POMC—epilepsy syndrome	1.37e-05	0.000108	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PRKCB—epilepsy syndrome	1.37e-05	0.000107	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—AGT—epilepsy syndrome	1.36e-05	0.000107	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL6ST—epilepsy syndrome	1.36e-05	0.000107	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—S100B—epilepsy syndrome	1.36e-05	0.000107	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SOCS3—epilepsy syndrome	1.35e-05	0.000106	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—JUNB—epilepsy syndrome	1.35e-05	0.000106	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SST—epilepsy syndrome	1.35e-05	0.000106	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CNR1—epilepsy syndrome	1.35e-05	0.000106	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCR2—epilepsy syndrome	1.35e-05	0.000106	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NTRK2—epilepsy syndrome	1.35e-05	0.000106	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CDC42—epilepsy syndrome	1.34e-05	0.000106	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PLCB1—epilepsy syndrome	1.34e-05	0.000105	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—DUSP6—epilepsy syndrome	1.33e-05	0.000105	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ADRA2A—epilepsy syndrome	1.32e-05	0.000104	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HTR7—epilepsy syndrome	1.31e-05	0.000103	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PLAT—epilepsy syndrome	1.31e-05	0.000103	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—S100B—epilepsy syndrome	1.3e-05	0.000102	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—AVP—epilepsy syndrome	1.3e-05	0.000102	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SOCS3—epilepsy syndrome	1.29e-05	0.000101	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CDC42—epilepsy syndrome	1.29e-05	0.000101	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HBEGF—epilepsy syndrome	1.28e-05	0.0001	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—BDKRB2—epilepsy syndrome	1.27e-05	9.95e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CXCL12—epilepsy syndrome	1.27e-05	9.95e-05	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—POMC—epilepsy syndrome	1.26e-05	9.94e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PRKCB—epilepsy syndrome	1.26e-05	9.91e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL6ST—epilepsy syndrome	1.26e-05	9.87e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—AKT3—epilepsy syndrome	1.25e-05	9.84e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—AVP—epilepsy syndrome	1.25e-05	9.8e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—POMC—epilepsy syndrome	1.24e-05	9.78e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—JUNB—epilepsy syndrome	1.24e-05	9.77e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CNR1—epilepsy syndrome	1.24e-05	9.77e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PLCB1—epilepsy syndrome	1.24e-05	9.73e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—HES1—epilepsy syndrome	1.23e-05	9.67e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ADAM10—epilepsy syndrome	1.22e-05	9.61e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CCL2—epilepsy syndrome	1.22e-05	9.57e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HTR7—epilepsy syndrome	1.21e-05	9.53e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—FYN—epilepsy syndrome	1.2e-05	9.4e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—H2AFX—epilepsy syndrome	1.19e-05	9.37e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MEF2C—epilepsy syndrome	1.19e-05	9.35e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—HES1—epilepsy syndrome	1.18e-05	9.27e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HBEGF—epilepsy syndrome	1.18e-05	9.25e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—S100B—epilepsy syndrome	1.16e-05	9.09e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—AKT3—epilepsy syndrome	1.16e-05	9.08e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—YWHAZ—epilepsy syndrome	1.15e-05	9.04e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—POMC—epilepsy syndrome	1.15e-05	9.02e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—FYN—epilepsy syndrome	1.15e-05	9.01e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SOCS3—epilepsy syndrome	1.14e-05	9e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—H2AFX—epilepsy syndrome	1.14e-05	8.98e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CDC42—epilepsy syndrome	1.14e-05	8.98e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MEF2C—epilepsy syndrome	1.14e-05	8.96e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NGF—epilepsy syndrome	1.14e-05	8.94e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ADAM10—epilepsy syndrome	1.13e-05	8.87e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CCL2—epilepsy syndrome	1.12e-05	8.83e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—AVP—epilepsy syndrome	1.11e-05	8.69e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCR5—epilepsy syndrome	1.11e-05	8.69e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.1e-05	8.66e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NGF—epilepsy syndrome	1.09e-05	8.57e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—HTR2A—epilepsy syndrome	1.08e-05	8.51e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—S100B—epilepsy syndrome	1.07e-05	8.39e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCR5—epilepsy syndrome	1.06e-05	8.33e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SOCS3—epilepsy syndrome	1.06e-05	8.31e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CDC42—epilepsy syndrome	1.05e-05	8.29e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HES1—epilepsy syndrome	1.05e-05	8.22e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—HTR2A—epilepsy syndrome	1.04e-05	8.16e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TSC2—epilepsy syndrome	1.03e-05	8.08e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—AGT—epilepsy syndrome	1.03e-05	8.07e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—AVP—epilepsy syndrome	1.02e-05	8.02e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—FYN—epilepsy syndrome	1.02e-05	7.99e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—H2AFX—epilepsy syndrome	1.01e-05	7.96e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MEF2C—epilepsy syndrome	1.01e-05	7.95e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—APOE—epilepsy syndrome	1.01e-05	7.91e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—KDR—epilepsy syndrome	9.86e-06	7.75e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TSC2—epilepsy syndrome	9.86e-06	7.75e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—AGT—epilepsy syndrome	9.84e-06	7.74e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—YWHAZ—epilepsy syndrome	9.77e-06	7.68e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NGF—epilepsy syndrome	9.67e-06	7.6e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HES1—epilepsy syndrome	9.65e-06	7.59e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—APOE—epilepsy syndrome	9.64e-06	7.58e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PRKCB—epilepsy syndrome	9.49e-06	7.46e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—KDR—epilepsy syndrome	9.45e-06	7.43e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL6ST—epilepsy syndrome	9.45e-06	7.43e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCR5—epilepsy syndrome	9.4e-06	7.39e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FYN—epilepsy syndrome	9.38e-06	7.38e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—H2AFX—epilepsy syndrome	9.35e-06	7.35e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MEF2C—epilepsy syndrome	9.33e-06	7.34e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HTR2A—epilepsy syndrome	9.2e-06	7.23e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PRKCB—epilepsy syndrome	9.1e-06	7.15e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL6ST—epilepsy syndrome	9.06e-06	7.12e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—YWHAZ—epilepsy syndrome	9.02e-06	7.09e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NGF—epilepsy syndrome	8.92e-06	7.01e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TSC2—epilepsy syndrome	8.74e-06	6.87e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—AGT—epilepsy syndrome	8.73e-06	6.86e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCR5—epilepsy syndrome	8.68e-06	6.82e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—POMC—epilepsy syndrome	8.64e-06	6.79e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—APOE—epilepsy syndrome	8.55e-06	6.72e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HTR2A—epilepsy syndrome	8.49e-06	6.67e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCL2—epilepsy syndrome	8.46e-06	6.65e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—KDR—epilepsy syndrome	8.38e-06	6.59e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—POMC—epilepsy syndrome	8.29e-06	6.51e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCL2—epilepsy syndrome	8.11e-06	6.37e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PRKCB—epilepsy syndrome	8.07e-06	6.34e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TSC2—epilepsy syndrome	8.07e-06	6.34e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—AGT—epilepsy syndrome	8.06e-06	6.33e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL6ST—epilepsy syndrome	8.03e-06	6.32e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—APOE—epilepsy syndrome	7.89e-06	6.21e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—KDR—epilepsy syndrome	7.73e-06	6.08e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—FGF2—epilepsy syndrome	7.64e-06	6.01e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PRKCB—epilepsy syndrome	7.44e-06	5.85e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL6ST—epilepsy syndrome	7.41e-06	5.83e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—POMC—epilepsy syndrome	7.35e-06	5.78e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—FGF2—epilepsy syndrome	7.33e-06	5.76e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCL2—epilepsy syndrome	7.19e-06	5.65e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—RELA—epilepsy syndrome	7.09e-06	5.58e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MTOR—epilepsy syndrome	6.96e-06	5.47e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—RELA—epilepsy syndrome	6.8e-06	5.35e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—POMC—epilepsy syndrome	6.78e-06	5.33e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MTOR—epilepsy syndrome	6.67e-06	5.24e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCL2—epilepsy syndrome	6.64e-06	5.22e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—FGF2—epilepsy syndrome	6.5e-06	5.11e-05	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—AKT1—epilepsy syndrome	6.46e-06	5.08e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CASP3—epilepsy syndrome	6.4e-06	5.03e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—JUN—epilepsy syndrome	6.22e-06	4.89e-05	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—AKT1—epilepsy syndrome	6.19e-06	4.87e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CASP3—epilepsy syndrome	6.13e-06	4.82e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MMP9—epilepsy syndrome	6.05e-06	4.75e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—RELA—epilepsy syndrome	6.03e-06	4.74e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FGF2—epilepsy syndrome	6e-06	4.71e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—JUN—epilepsy syndrome	5.96e-06	4.68e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MTOR—epilepsy syndrome	5.92e-06	4.65e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—AKT1—epilepsy syndrome	5.86e-06	4.61e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MMP9—epilepsy syndrome	5.8e-06	4.56e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—AKT1—epilepsy syndrome	5.62e-06	4.42e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SRC—epilepsy syndrome	5.57e-06	4.38e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—RELA—epilepsy syndrome	5.57e-06	4.38e-05	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—AKT1—epilepsy syndrome	5.49e-06	4.32e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MTOR—epilepsy syndrome	5.46e-06	4.29e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CASP3—epilepsy syndrome	5.44e-06	4.28e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—VEGFA—epilepsy syndrome	5.43e-06	4.27e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SRC—epilepsy syndrome	5.34e-06	4.2e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—JUN—epilepsy syndrome	5.28e-06	4.15e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—VEGFA—epilepsy syndrome	5.21e-06	4.09e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MMP9—epilepsy syndrome	5.14e-06	4.04e-05	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—AKT1—epilepsy syndrome	5.07e-06	3.98e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CASP3—epilepsy syndrome	5.02e-06	3.95e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—AKT1—epilepsy syndrome	4.99e-06	3.92e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—JUN—epilepsy syndrome	4.88e-06	3.83e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MMP9—epilepsy syndrome	4.74e-06	3.73e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SRC—epilepsy syndrome	4.74e-06	3.73e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—VEGFA—epilepsy syndrome	4.62e-06	3.63e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—AKT1—epilepsy syndrome	4.6e-06	3.62e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SRC—epilepsy syndrome	4.37e-06	3.44e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—VEGFA—epilepsy syndrome	4.26e-06	3.35e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—AKT1—epilepsy syndrome	3.46e-06	2.72e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—AKT1—epilepsy syndrome	3.32e-06	2.61e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—AKT1—epilepsy syndrome	2.95e-06	2.32e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—AKT1—epilepsy syndrome	2.72e-06	2.14e-05	CbGpPWpGaD
